Johnson & Johnson (JNJ) Tops Q2 EPS by 5c; Reaffirms Guidance
Tweet Send to a Friend
Get Alerts JNJ Hot Sheet
Price: $88.09 +0.73%
EPS Growth %: +5.1%
Financial Fact:
Earnings before provision for taxes on income: 4.26B
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +5.1%
Financial Fact:
Earnings before provision for taxes on income: 4.26B
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade JNJ Now!
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.28, $0.05 better than the analyst estimate of $1.23. Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.22 billion.
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
- Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot List
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
